Study Refines Renal Dosing of Daptomycin for Staph BacteremiaStudy Refines Renal Dosing of Daptomycin for Staph Bacteremia

A new study from Novartis Pharma helps quantify the best daptomycin regimen for patients with renal impairment and Staphylococcus aureus (MRSA) bacteremia. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news